Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 4716.23 | 243 / 245 | 99% | 121.30 | 498 / 502 |
intestine | 100% | 2547.68 | 963 / 966 | 98% | 48.98 | 519 / 527 |
stomach | 100% | 1705.92 | 358 / 359 | 98% | 45.15 | 281 / 286 |
lung | 100% | 2581.67 | 577 / 578 | 95% | 27.03 | 1102 / 1155 |
ovary | 99% | 4451.47 | 179 / 180 | 94% | 22.21 | 405 / 430 |
brain | 95% | 2231.90 | 2502 / 2642 | 99% | 60.00 | 697 / 705 |
breast | 100% | 1980.54 | 458 / 459 | 93% | 25.91 | 1043 / 1118 |
liver | 100% | 4782.73 | 226 / 226 | 93% | 31.80 | 377 / 406 |
pancreas | 97% | 1199.37 | 319 / 328 | 94% | 25.99 | 167 / 178 |
skin | 100% | 3589.17 | 1809 / 1809 | 91% | 28.50 | 428 / 472 |
bladder | 95% | 2439.24 | 20 / 21 | 94% | 36.22 | 474 / 504 |
esophagus | 91% | 2348.69 | 1311 / 1445 | 98% | 34.78 | 180 / 183 |
uterus | 100% | 1725.93 | 170 / 170 | 88% | 25.36 | 405 / 459 |
thymus | 100% | 1526.04 | 650 / 653 | 77% | 14.14 | 467 / 605 |
adrenal gland | 100% | 8736.76 | 258 / 258 | 63% | 24.58 | 146 / 230 |
kidney | 99% | 1307.30 | 88 / 89 | 58% | 9.16 | 524 / 901 |
adipose | 100% | 1890.20 | 1203 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 1107.27 | 238 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 26.95 | 42 / 45 |
heart | 87% | 912.55 | 753 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 82% | 764.39 | 1098 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 67% | 759.43 | 626 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 35% | 5.34 | 28 / 80 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.72 | 5 / 29 |
muscle | 9% | 61.05 | 69 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1904219 | Biological process | positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity |
GO_0042552 | Biological process | myelination |
GO_1904222 | Biological process | positive regulation of serine C-palmitoyltransferase activity |
GO_0045087 | Biological process | innate immune response |
GO_0006658 | Biological process | phosphatidylserine metabolic process |
GO_0051607 | Biological process | defense response to virus |
GO_0009597 | Biological process | detection of virus |
GO_0008654 | Biological process | phospholipid biosynthetic process |
GO_0015825 | Biological process | L-serine transport |
GO_0006564 | Biological process | L-serine biosynthetic process |
GO_0043209 | Cellular component | myelin sheath |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005829 | Cellular component | cytosol |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0015194 | Molecular function | L-serine transmembrane transporter activity |
Gene name | SERINC5 |
Protein name | Serine incorporator 5 |
Synonyms | C5orf12 |
Description | FUNCTION: Restriction factor required to restrict infectivity of lentiviruses, such as HIV-1: acts by inhibiting an early step of viral infection. Impairs the penetration of the viral particle into the cytoplasm . Enhances the incorporation of serine into phosphatidylserine and sphingolipids. May play a role in providing serine molecules for the formation of myelin glycosphingolipids in oligodendrocytes (By similarity). . |
Accessions | ENST00000512972.6 [Q86VE9-3] ENST00000509193.5 [Q86VE9-2] ENST00000632581.1 A0A0J9YYI4 ENST00000507668.7 [Q86VE9-4] Q86VE9 |